ABCG2
protein-codingATP binding cassette subfamily G member 2 (Junior blood group), the group of ATP binding cassette subfamily G|CD molecules|Blood group antigens
Gene summary
The membrane-associated protein encoded by this gene is included in the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. Alternatively referred to as a breast cancer resistance protein, this protein functions as a xenobiotic transporter which may play a major role in multi-drug resistance. It likely serves as a cellular defense mechanism in response to mitoxantrone and anthracycline exposure. Significant expression of this protein has been observed in the placenta, which may suggest a potential role for this molecule in placenta tissue. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~141.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
Clinical Genomic Database (CGD)
Manifestation: Hematologic
Intervention: Hematologic
Rationale: Variants associated with a blood group may be important in specific situations (eg, related to transfusion)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ABCG2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004827.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | 2 | |||
| missense | 47 | 3 | 50 | |||
| nonsense | 4 | 4 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 2 | 3 | |||
| splice donor/acceptor (+/-2bp) | 4 | 4 | ||||
| Total | 0 | 1 | 57 | 4 | 1 | 63 |
Highest pathogenic variant AF is 0.00004337056
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004818.2 | 15 | MANE Select | |
| Ensembl | ENSP00000237612.3 | 15 | MANE Select | |
| RefSeq | NP_001244315.1 | 15 | Standard | |
| RefSeq | NP_001335914.1 | 15 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Methotrexate Pathway (Brain Cell), Pharmacokinetics
- Methotrexate Pathway, Pharmacokinetics
- Doxorubicin Pathway (Cancer Cell), Pharmacodynamics
- Bile secretion - Homo sapiens (human)
- ABC transporters - Homo sapiens (human)
Biological Process
- drug transmembrane transport
- cellular iron ion homeostasis
- heme transport
- response to drug
- xenobiotic transport
Molecular Function
- transporter activity
- protein binding
- ATP binding
- xenobiotic transmembrane transporting ATPase activity
- heme transporter activity
Cellular Component
- nucleus
- plasma membrane
- integral component of membrane
- mitochondrial membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000237612
- Coding exons
- 15
- Length
- 141059
- Individuals with no LoFs
- 125263
- Homozygous LoFs
- 4
- Heterozygous LoFs
- 481
- Defined
- 125748
- p
- 0.00193
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.881 | 400 | 353 | 1.13 | 0.0000181 | 4266 |
| Missense (PolyPhen) | 89 | 74.344 | 1.1971 | 903 | ||
| Synonymous | 0.690 | 123 | 133 | 0.924 | 0.00000735 | 1274 |
| Loss of Function | -1.15 | 44 | 36.5 | 1.21 | 0.00000222 | 430 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00086 | 0.00086 | rare |
| Latino/Admixed American | 0.0017 | 0.0017 | notable |
| Ashkenazi Jewish | 0.0014 | 0.0014 | notable |
| East Asian | 0.0075 | 0.0075 | notable |
| Finnish | 0.000092 | 0.000092 | rare |
| European (Non-Finnish) | 0.0012 | 0.0012 | notable |
| South Asian | 0.0037 | 0.0035 | notable |
| Other | 0.0018 | 0.0018 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: High-capacity urate exporter functioning in both renal and extrarenal urate excretion. Plays a role in porphyrin homeostasis as it is able to mediates the export of protoporhyrin IX (PPIX) both from mitochondria to cytosol and from cytosol to extracellular space, and cellular export of hemin, and heme. Xenobiotic transporter that may play an important role in the exclusion of xenobiotics from the brain. Appears to play a major role in the multidrug resistance phenotype of several cancer cell lines. Implicated in the efflux of numerous drugs and xenobiotics: mitoxantrone, the photosensitizer pheophorbide, camptothecin, methotrexate, azidothymidine (AZT), and the anthracyclines daunorubicin and doxorubicin. {ECO:0000269|PubMed:12958161, ECO:0000269|PubMed:20705604, ECO:0000269|PubMed:22132962, ECO:0000269|PubMed:23189181}.;
Recessive Scores
- pRec
- 0.552
Intolerance Scores
- LoFtool
- 0.454
- RVIS EVS
- -0.2
- RVIS percentile EVS
- 39.17
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.166
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |